Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$20.67

0.21 (1.03%)

04:55
10/06/16
10/06
04:55
10/06/16
04:55

Acorda Therapeutics management to meet with Evercore ISI

Meeting to be held in New York on October 6 hosted by Evercore ISI.

  • 06

    Oct

ACOR Acorda Therapeutics
$20.67

0.21 (1.03%)

03/30/16
GSCO
03/30/16
INITIATION
Target $23
GSCO
Sell
Acorda Therapeutics initiated with a Sell at Goldman
Goldman Sachs analyst Salveen Richter started Acorda Therapeutics with a Sell rating and $23 price target. The analyst believes Acorda's lead product Ampyra is close to fully realizing its commercial opportunity and that intellectual property threats will present an overhang on the shares.
03/30/16
GSCO
03/30/16
DOWNGRADE
Target $10
GSCO
Neutral
Dimension Therapeutics downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Salveen Richter downgraded Dimension Therapeutics (DMTX) to Neutral saying other names in the sector offer better near-term opportunities. The analyst views Dimension as well-positioned in the gene therapy space, however. He lowered his price target for the shares to $10 from $12. Richter this morning also initiated SAGE Therapeutics (SAGE) with a Buy rating and Acorda Therapeutics (ACOR) with a Sell rating.
03/30/16
03/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Intercept (ICPT) initiated with an Outperform and a Neutral at Credit Suisse and Goldman, respectively. Goldman Sachs analyst Salveen Richter said investor expectations into the April 7 FDA panel for obeticholic acid in primary biliary cholangitis appear high. 2. Acorda Therapeutics (ACOR) initiated with a Sell at Goldman by analyst Salveen Richter, who said Acorda's lead product Ampyra is close to fully realizing its commercial opportunity and that intellectual property threats will present an overhang on the shares. 3. SAGE Therapeutics (SAGE) initiated with a Buy at Goldman due to the belief that the company is a key player in acute central nervous system disorders. 4. Rio Tinto (RIO) initiated with a Buy at Argus. 5. Square (SQ) initiated with a Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
LEER
10/04/16
INITIATION
Target $25
LEER
Market Perform
Acorda Therapeutics reinstated with a Market Perform at Leerink
Leerink analyst Paul Matteis resumed coverage of Acorda Therapeutics with a Market Perform rating and $25 price target.

TODAY'S FREE FLY STORIES

08:40
02/27/17
02/27
08:40
02/27/17
08:40
General news
U.S. durable goods orders rebounded 1.8% in January »

U.S. durable goods orders…

ERIC

Ericsson

$6.45

-0.08 (-1.23%)

, QCOM

Qualcomm

$57.22

0.08 (0.14%)

08:39
02/27/17
02/27
08:39
02/27/17
08:39
Conference/Events
Drexel Hamilton Events at Mobile World Congress »

Meetings with various…

ERIC

Ericsson

$6.45

-0.08 (-1.23%)

QCOM

Qualcomm

$57.22

0.08 (0.14%)

CSCO

Cisco

$34.32

0.28 (0.82%)

SNCR

Synchronoss

$30.49

-0.37 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

  • 13

    Mar

  • 29

    Mar

REGN

Regeneron

$361.01

0.05 (0.01%)

, SNY

Sanofi

$42.70

0.19 (0.45%)

08:39
02/27/17
02/27
08:39
02/27/17
08:39
Hot Stocks
Regeneron, Sanofi to present new data on DUPIXENT at AAD »

Regeneron Pharmaceuticals…

REGN

Regeneron

$361.01

0.05 (0.01%)

SNY

Sanofi

$42.70

0.19 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 09

    Mar

  • 17

    Mar

  • 29

    Mar

LAUR

Laureate Education

$13.24

0.06 (0.46%)

08:38
02/27/17
02/27
08:38
02/27/17
08:38
Initiation
Laureate Education initiated  »

Laureate Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$21.60

0.02 (0.09%)

08:37
02/27/17
02/27
08:37
02/27/17
08:37
Initiation
Invitation Homes initiated  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$15.65

-0.02 (-0.13%)

, YDKN

Yadkin Financial

$33.42

-0.14 (-0.42%)

08:37
02/27/17
02/27
08:37
02/27/17
08:37
Hot Stocks
F.N.B. receives final regulatory approvals for proposed merger of Yadkin Financial »

F.N.B. (FNB) announced…

FNB

F.N.B.

$15.65

-0.02 (-0.13%)

YDKN

Yadkin Financial

$33.42

-0.14 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENB

Enbridge

$41.34

-0.37 (-0.89%)

, SE

Spectra Energy

$40.68

-0.32 (-0.78%)

08:36
02/27/17
02/27
08:36
02/27/17
08:36
Hot Stocks
Enbridge, Spectra Energy complete merger »

Enbridge (ENB) announced…

ENB

Enbridge

$41.34

-0.37 (-0.89%)

SE

Spectra Energy

$40.68

-0.32 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

OTIV

On Track Innovations

$1.99

-0.08 (-3.86%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Hot Stocks
On Track Innovations announces appointment of VP of Sales »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$52.63

0.12 (0.23%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$46.96

-0.24 (-0.51%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Hot Stocks
Eaton Vance expands presence in Japan »

Eaton Vance announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRI

Silver Standard

$11.53

0.63 (5.78%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Recommendations
Silver Standard analyst commentary  »

Silver Standard reproted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$57.81

-0.68 (-1.16%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Hot Stocks
Buffett says Wells Fargo made 'huge mistake' »

Warren Buffett said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

XLE

Energy Select Sector SPDR

$70.99

-0.67 (-0.93%)

08:35
02/27/17
02/27
08:35
02/27/17
08:35
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:35
02/27/17
02/27
08:35
02/27/17
08:35
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

XLY

Consumer Discretionary Sector SPDR

$86.92

0.4 (0.46%)

08:34
02/27/17
02/27
08:34
02/27/17
08:34
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENFC

Entegra Financial

$23.15

0.05 (0.22%)

08:34
02/27/17
02/27
08:34
02/27/17
08:34
Hot Stocks
Entegra Financial completes purchase of 2 branches in Northern Georgia »

Entegra Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$52.43

0.11 (0.21%)

08:34
02/27/17
02/27
08:34
02/27/17
08:34
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$51.59

0.77 (1.52%)

08:33
02/27/17
02/27
08:33
02/27/17
08:33
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPE

Ampio

$0.80

-0.0312 (-3.75%)

08:33
02/27/17
02/27
08:33
02/27/17
08:33
Hot Stocks
Ampio: OTAT provides guidance for path to approval of Ampion »

Ampio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSN

Celsion

$0.21

-0.0229 (-9.83%)

08:33
02/27/17
02/27
08:33
02/27/17
08:33
Hot Stocks
Celsion sees OVATION study to be fully enrolled, data to come in Q2 »

Celsion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.28

0.19 (0.34%)

08:33
02/27/17
02/27
08:33
02/27/17
08:33
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$74.78

0.36 (0.48%)

08:33
02/27/17
02/27
08:33
02/27/17
08:33
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$30.49

-0.37 (-1.20%)

08:32
02/27/17
02/27
08:32
02/27/17
08:32
Hot Stocks
Synchronoss names John Frederick as CFO, effective immediately »

Synchronoss Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

IWM

iShares Trust Russell 2000 Index Fund

$138.65

-0.1 (-0.07%)

08:32
02/27/17
02/27
08:32
02/27/17
08:32
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$207.93

0.11 (0.05%)

08:32
02/27/17
02/27
08:32
02/27/17
08:32
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.